Circular RNA MYLK promotes hepatocellular carcinoma progression by increasing Rab23 expression by sponging miR-362-3p

Table 2 Correlation between clinical pathological characteristic and MYLK expression in HCC (n = 62)

Parameters	Group	n	MYLK expression		P value
Parameters	Group	n	High (n = 31)	Low (n = 31)	P value
Age (years)	≤ 60	28	13	15	0.515
Age (years)	> 60	34	18	16
Gender	Female	18	11	7	0.302
Gender	Male	44	20	24
Cirrhosis	Positive	25	15	10	0.626
Cirrhosis	Negative	37	16	21	0.626
AFP (ng/ml)	≤ 400	30	14	16	0.728
AFP (ng/ml)	> 400	32	17	15
Tumor size (cm)	≥ 5	38	28	10	0.003**
Tumor size (cm)	< 5	24	3	21
Intrahepatic metastasis	Positive	21	5	16	0.022*
Intrahepatic metastasis	Negative	41	26	15	0.022*
Extrahepatic metastasis	Positive	19	2	17	0.004**
Extrahepatic metastasis	Negative	43	29	14	0.004**
BCLC stage	A	12	2	10	0.065
	B	34	20	14
	C	16	9	7
Differentiation	Well-moderate	38	20	18	0.173
Differentiation	Moderate to low–low	24	11	13

ISSN: 1475-2867